GoodRx (GDRX) CFO Justin Fengler RSUs Vest; Taxes Withheld

What Happened

• Justin Fengler, GoodRx’s Chief Financial Officer and Chief Strategy & Operations Officer, had restricted stock units (RSUs) convert into 3,087 shares on 2026-09-15. To cover tax withholding, 1,354 shares were surrendered at $3.56 per share (total reported withholding ~$4,820). Net shares delivered to Mr. Fengler: 1,733. This was a compensation-related vesting event (not an open-market buy or sell).

Key Details

• Transaction date: 2026-09-15; Filing date/Period of report: 2026-09-15 (filed same day).
• RSUs converted (code M): 2,335 and 752 shares = 3,087 shares acquired on conversion.
• Tax withholding (code F): 1,024 shares withheld for $3,645 and 330 shares withheld for $1,175 (combined ~$4,820).
• Derivative entries showing disposals at $0.00 reflect cancellation/settlement of the RSU awards upon conversion.
• Shares owned after transaction: not provided in the excerpt of the filing.
• No indication this filing was late.

Context

• These entries reflect RSU vesting and a common “net share settlement”/tax-withholding process (shares withheld instead of cash payment), not a market sale or purchase.
• Footnotes: each RSU equals one share; the awards vest in quarterly installments (1/16 each quarter) per the schedules noted in the filing (one award began vesting June 15, 2024; the other began Dec 15, 2025).